Patents Assigned to Aventis Pasteur, Ltd.
  • Tumor antigen BFA5 for prevention and / or treatment of cancer
    Publication number: 20050112099
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
    Type: Application
    Filed: April 15, 2004
    Publication date: May 26, 2005
    Applicant: Aventis Pasteur, Ltd.
    Inventors: Neil Berinstein, Scott Gallichan, Corey Lovitt, Mark Parrington, Artur Pedyczak, Laszlo Radvanyi, Devender Singh-Sandhu
  • Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer
    Publication number: 20040197912
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
    Type: Application
    Filed: July 1, 2003
    Publication date: October 7, 2004
    Applicant: Aventis Pasteur, Ltd.
    Inventors: Neil Berinstein, Corey Lovitt, Mark Parrington, Artur Pedyczak, Laszlo Radvanyi, Scott Gallichan, Devender Singh-Sandhu, Raymond P. Oomen, Shi-Xian Cao
  • Targeted immunogens
    Publication number: 20040002455
    Abstract: The present invention provides reagents and methods for producing and utilizing targeted immunogens. In preferred embodiments, an immunogen is conjugated to an amino acid sequence that targets the immunogen to the MHC presentation pathway. Using the reagents and methods provided herein, immunization protocols may be enhanced resulting in increased immunity of the host.
    Type: Application
    Filed: January 29, 2003
    Publication date: January 1, 2004
    Applicants: Aventis Pasteur, Ltd., Aventis Pharmaceuticals, Inc.
    Inventors: Robert Adam Uger, Danielle Salha, Brian Barber, Clarence C. Morse, Yong Guo, Su Cheng
  • Immunogenic targets for melanoma
    Publication number: 20030113919
    Abstract: The present invention relates to peptides, polypeptides, and nucleic acids and the use of the peptide, polypeptide or nucleic acid in preventing and/or treating cancer. In particular, the invention relates to peptides and nucleic acid sequences encoding such peptides for use in diagnosing, treating, or preventing melanoma.
    Type: Application
    Filed: August 15, 2002
    Publication date: June 19, 2003
    Applicant: Aventis Pasteur, Ltd.
    Inventors: Peter Emtage, Liza Karunakaran, Artur Pedyczak, Brian Barber